kinetic study on the reactions of platinum drugs with glutathione

kinetic study on the reactions of platinum drugs with glutathione Proposed mechanism for the reduction

Name: kinetic study on the reactions of platinum drugs with glutathione Proposed mechanism for the reduction
Brand: crisbcreativa.com
SKU: 38375102701
Price: 20.85 USD
Availability: InStock
Rating: 4.809100000000001 (11 reviews)

Proposed mechanism for the reduction of cis,cis,trans [Pt(NH3)2Cl2Br2] Download Scientific Diagram Glutathione Mediated Conjugation of Anticancer Drugs Encyclopedia MDPI A cisplatin based platinum(IV) prodrug containing a glutathione s transferase inhibitor to reverse cisplatin resistance in non small cell lung cancer ScienceDirect kinetic study on the reactions of platinum drugs with glutathione Catalytic Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium Flavin Catalyst Chemical Imaging of Platinum Based Drugs Influence of chemical structure and mechanism of hydrolysis on pharmacological activity and toxicological profile of approved platinum drugs

SKU: 38375102701 · From crisbcreativa.com

4.8

USD20.85 USD54.85

Pay in 4 interest-free payments of $5.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Carbamidomethylation was set as a fixed modification, whereas methionine oxidation, asparagine and glutamine deamination, and glycosylation options were set as variable modifications, according to published data ( The intact hCG analysis revealed several hCG glycoforms

Zhao XY, Li SS, He YX, Yan LJ, Lv F, Liang QM et al (2023) SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy